Axsome Therapeutics (AXSM) PT Raised to $71 at Jefferies; 'Approval Imminent'

November 8, 2021 1:14 PM EST Send to a Friend
Jefferies analyst Chris Howerton raised the price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login